HOSPITAL support services-based Faber Group Bhd is now seen to be in a healthier position with the completion of its restructuring exercise last year, which saw its liabilities reduced to RM250mil from RM1.2bil previously.
AmResearch, in recommending a “buy” on Faber shares, said the company's stock valuation was attractive with its strong balance sheet and healthy prospects.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!